Kick-off discussion – Flu Forward: Influenza innovation for healthy ageing
Date: Tuesday 26 May 2026
Time: 12.30pm – 1:30pm BST
Location: Zoom
Vaccination is fundamental to healthy ageing, but its value extends far beyond simply preventing infectious diseases. Growing evidence demonstrates that influenza (flu) vaccines also actively reduce the risk of non-communicable diseases (NCDs), offering profound public health benefits outside their traditional scope. To maximise these population-wide outcomes, policymakers must look past the original design of immunisation programmes and actively champion flu vaccination as a vital, dual-purpose strategy for both infection control and NCD prevention.
As part of our Flu Forward project, the International Longevity Centre UK (ILC) is bringing together a diverse group of people to:
- Develop a consensus statement on influenza vaccination and healthy ageing that will inform future policy and advocacy.
- Contribute to the framing of new evidence on the health and economic value of preventing hospitalisations, including cardiorespiratory events.
- Influence the policy agenda around how vaccination is integrated into cardiovascular, multimorbidity and healthy ageing strategies.
- Define priorities for decision-makers – including how prevention should be valued in health technology assessment, procurement and health system planning.
- Join a cross-sector network of policymakers, clinicians, researchers and advocates working to strengthen adult immunisation policy.
During this project kick-off discussion, we heard from health stakeholders on how best to steer our project and develop a consensus statement that outlines the need for improved flu vaccination to support healthy ageing.
This project has been financially supported by Sanofi.
